• Subject: Re: IFS open scope
  • From: "Peter Dow" <pcdow@xxxxxxxxxxxxxxx>
  • Date: Fri, 10 Nov 2000 10:12:23 -0800

Hi Jon,

Well, let's see. The service program that actually opens the file is running
in ACTGRP(*CALLER), as is the RPGLE program that called it. Prior to that is
a CLP, which is an OPM, so yes, it apparently is running in the default
activation group.

Thanks Jon! That did the job -- I changed the CLP to a CLLE and made it run
in a new activation group. A forced failure cleaned up the activation group
and closed the files.

I love this list!!

Regards,
Peter Dow
Dow Software Services, Inc.
909 425-0194 voice
909 425-0196 fax


----- Original Message -----
From: <Jon.Paris@hal.it>
To: <midrange-l@midrange.com>
Sent: Friday, November 10, 2000 6:06 AM
Subject: IFS open scope


> >> When using the IFS open() API to open a QSYS.LIB file, if the calling
> program fails before close()ing the file,
>
> Are you by any chance running this program in the default Activation
Group?
> That would be my guess.
>
> +---
> | This is the Midrange System Mailing List!
> | To submit a new message, send your mail to MIDRANGE-L@midrange.com.
> | To subscribe to this list send email to MIDRANGE-L-SUB@midrange.com.
> | To unsubscribe from this list send email to
MIDRANGE-L-UNSUB@midrange.com.
> | Questions should be directed to the list owner/operator:
david@midrange.com
> +---

+---
| This is the Midrange System Mailing List!
| To submit a new message, send your mail to MIDRANGE-L@midrange.com.
| To subscribe to this list send email to MIDRANGE-L-SUB@midrange.com.
| To unsubscribe from this list send email to MIDRANGE-L-UNSUB@midrange.com.
| Questions should be directed to the list owner/operator: david@midrange.com
+---

This thread ...

Replies:

Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2019 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].